SOY 300MG CAPSULE

Indications

• Bladder irrigation during urological surgery
• Irrigation for transurethral resection of the prostate gland
• Irrigation for bladder tumors

Dosage

Children: Refer to the BNF for Children for pediatric dosing guidelines.

Adults: Refer to the product literature for specific dosing information.

Mechanism of action

Glycine binds to strychnine-sensitive and strychnine-insensitive glycine receptors in the central nervous system. The strychnine-sensitive receptor is a chloride channel that enhances inhibitory neurotransmission. This action may contribute to glycine's potential antispastic effects. Additionally, glycine potentiates NMDA receptor-mediated neurotransmission, which may have implications in managing certain neurological conditions, such as neuroleptic-resistant negative symptoms in schizophrenia.

Pharmacodynamics

Glycine plays a crucial role in various biological functions, including energy metabolism and immune response. It is involved in hormone synthesis and helps in modulating neurotransmitter release, particularly in inhibitory pathways. Glycine's ability to enhance chloride conductance in neurons contributes to its antispastic properties and its potential to mitigate oxidative stress in immune responses.

Pharmacokinetics

Glycine is absorbed readily in the gastrointestinal tract and is utilized by the body for protein synthesis and other metabolic functions. The distribution of glycine in the body is widespread, as it is present in various tissues. Glycine is metabolized in the liver and other tissues, with excretion primarily occurring via the kidneys. The pharmacokinetics of glycine can be influenced by factors such as age, renal function, and overall health status.

Adverse effects

• Fluid overload
• Electrolyte imbalance
• Nausea
• Vomiting
• Headache
• Hypotension

Precautions

• Monitor for signs of fluid overload during irrigation
• Use caution in patients with pre-existing electrolyte imbalances
• Careful consideration in patients with renal impairment

Pregnancy

Glycine is generally considered safe for use during pregnancy when used as an irrigation solution, but risks should be discussed with a healthcare provider.

Breast-feeding

Glycine is likely safe during breastfeeding, but limited data is available. Consultation with a healthcare professional is advisable.

Storage

Store in a cool, dry place. Protect from light. Do not freeze.

Formulations

• Glycine 1.5% irrigation solution 3 litre Easyflow bags
• Glycine 1.5% irrigation solution 1 litre Flowfusor bottles
• Glycine 1.5% irrigation solution 1 litre Easyflow bags
• Glycine 1.5% irrigation solution 2 litre Flowfusor bottles

Indications

• Vitiligo
• Hyperpigmentation disorders

Dosage

Children: Refer to BNF for Children for specific dosing guidance.

Adults: Refer to BNF for specific dosing guidance.

Mechanism of action

Monobenzone acts as a depigmenting agent through an incompletely understood mechanism. It is suggested that monobenzone increases the excretion of melanin from melanocytes and interferes with the biosynthesis of melanin by inhibiting the enzyme tyrosinase. This inhibition prevents the conversion of tyrosine to dihydroxyphenylalanine, which is a precursor of melanin. As a result, the drug leads to depigmentation, especially in areas with existing hyperpigmentation, while the epidermis remains intact but lacks identifiable melanocytes.

Pharmacodynamics

Monobenzone is the monobenzyl ether of hydroquinone. It functions as a topical agent that permanently removes color from normal skin surrounding areas affected by vitiligo. By inhibiting the production of melanin, monobenzone reduces skin pigmentation and facilitates a more uniform skin tone over time. The effect is particularly pronounced in hyperpigmented skin, which fades more quickly than normal skin.

Pharmacokinetics

The pharmacokinetics of monobenzone are not extensively detailed in available literature. However, it is primarily applied topically, and its systemic absorption is likely minimal. The onset of action can vary, with effects typically observable within one to four months. The drug is metabolized within the skin, and its efficacy can be influenced by factors such as sun exposure, which can reduce its depigmenting effects.

Adverse effects

• Skin irritation
• Erythema
• Contact dermatitis
• Dry skin
• Photosensitivity

Precautions

• Avoid contact with eyes
• Not for use on broken skin
• Avoid excessive sun exposure

Pregnancy

There are no adequate and well-controlled studies in pregnant women. Use only if clearly needed.

Breast-feeding

There is no information available regarding the excretion of monobenzone in human milk. Caution should be exercised.

Storage

Store at room temperature, away from light and moisture. Keep out of reach of children.

Formulations

• Topical cream
• Topical lotion

Indications

• Immune system support
• Chronic fatigue syndrome
• Stress relief
• Sleep disorders
• Anticancer therapy adjunct
• Cardiovascular health support
• Liver health support

Dosage

Children: Refer to specific product guidelines and consult a healthcare provider, as safety and efficacy in children have not been well established.

Adults: Refer to specific product guidelines, as dosages vary based on formulation and health benefit sought.

Mechanism of action

Ganoderma contains bioactive compounds such as triterpenes, polysaccharides, and peptidoglycans that contribute to its pharmacological effects. The triterpenes are believed to inhibit the production of pro-inflammatory cytokines, while polysaccharides may enhance immune function by stimulating macrophage activity. This leads to increased immune response and potential antitumor activity.

Pharmacodynamics

Ganoderma exhibits various pharmacodynamic effects including immunomodulation, antioxidant activity, and anti-inflammatory effects. The active compounds can enhance the proliferation of immune cells like T-cells and natural killer cells, thereby boosting the body's defense mechanisms. Additionally, the antioxidant properties help in scavenging free radicals, which may protect cells from oxidative stress.

Pharmacokinetics

The pharmacokinetic profile of Ganoderma is not well-characterized due to variability in extraction methods and formulations. However, studies suggest that its active compounds are absorbed in the gastrointestinal tract, with polysaccharides being metabolized by gut microbiota. The elimination half-life and specific metabolic pathways of Ganoderma's constituents remain largely undefined.

Adverse effects

• Nausea
• Diarrhea
• Dry mouth
• Dizziness
• Allergic reactions

Interactions

• Anticoagulants (e.g., warfarin) - may increase bleeding risk
• Antidiabetic medications - may enhance effects and cause hypoglycemia
• Immunosuppressants - may interfere with their effectiveness

Precautions

• Use with caution in patients with bleeding disorders
• Monitor blood glucose levels in diabetic patients
• Consult healthcare provider before use in pregnant or breastfeeding women

Pregnancy

There is insufficient evidence to determine safety during pregnancy. Use with caution and consult a healthcare professional.

Breast-feeding

Limited data is available; consult a healthcare provider before use while breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Powder
• Capsules
• Extracts
• Tea

Indications

• Menopausal symptoms
• Cardiovascular health
• Bone health
• Estrogen-dependent cancers

Dosage

Children: Use in children is not

Adults: Dosage varies based on the specific formulation and indication. Refer to the specific product guidelines or the BNF for detailed dosing recommendations.

Mechanism of action

Isoflavones are selective estrogen receptor modulators that exert estrogenic-like effects under certain conditions. They bind preferentially to estrogen receptor beta (ERβ) with a binding affinity approximately 20 times higher than that to estrogen receptor alpha (ERα). Isoflavones can exhibit antiestrogenic actions by blocking the binding of endogenous estrogens and their receptor signaling. They may inhibit the proliferation of breast cancer cells by arresting cell cycle progression and inducing apoptosis. Additionally, isoflavones may act on androgen receptors to inhibit tyrosine kinase activity, blocking cancer cell growth.

Pharmacodynamics

Isoflavones, particularly from soy, have been shown to lower LDL cholesterol levels and improve blood pressure in women with hypertension. In postmenopausal women, dietary intake of isoflavones has been associated with reduced bone resorption and increased bone formation markers. Their effects on menopausal symptoms, breast cancer, and prostate cancer remain controversial, though some studies suggest they may decrease cancer development markers in prostate cells.

Pharmacokinetics

Isoflavones are metabolized in the gut and liver, leading to various bioactive metabolites. Their bioavailability can be affected by dietary factors and individual metabolism. Peak plasma concentrations occur about 2 to 4 hours after ingestion, with a half-life that varies depending on the specific isoflavone and individual factors. Isoflavones are primarily excreted via urine.

Adverse effects

• gastrointestinal disturbances
• allergic reactions
• headaches
• fatigue
• dizziness

Interactions

• may interact with anticoagulants, potentially increasing bleeding risk
• may affect the metabolism of certain medications via CYP450 enzymes
• estrogenic drugs may exhibit compounded effects when used with isoflavones

Precautions

• use cautiously in individuals with hormone-sensitive conditions
• monitor patients with a history of breast or prostate cancer
• consider potential interactions with other medications

Pregnancy

Isoflavones should be used with caution during pregnancy due to their estrogen-like effects; consult healthcare professionals for guidance.

Breast-feeding

Limited data is available; consult healthcare professionals before use during breastfeeding.

Storage

Store in a cool, dry place, away from direct sunlight.

Formulations

• capsules
• tablets
• powdered supplements
• soy-based food products

Indications

• Inflammatory conditions
• Pain management
• Hepatic disorders
• Menstrual irregularities
• Anxiety and stress-related disorders

Dosage

Children: Refer to established guidelines or product-specific information for pediatric dosing recommendations, as specific doses can vary based on the formulation and indication.

Adults: Refer to established guidelines or product-specific information for dosing recommendations, as specific doses can vary based on the formulation and indication.

Mechanism of action

The active compounds in Paeoniae may exert their effects through multiple mechanisms, including modulation of inflammatory mediators and antioxidant activity. Some studies suggest that it may inhibit the production of pro-inflammatory cytokines and promote the expression of anti-inflammatory cytokines, thereby reducing inflammation. Additionally, certain components may enhance blood circulation and exert a mild sedative effect.

Pharmacodynamics

Paeoniae exhibits a range of pharmacological activities, including anti-inflammatory, analgesic, and calming effects. The anti-inflammatory properties are thought to be mediated by the inhibition of cyclooxygenase and lipoxygenase pathways, which are critical in the synthesis of inflammatory mediators. The calming effects may be due to its ability to modulate neurotransmitter levels, including GABA.

Pharmacokinetics

The pharmacokinetic profile of Paeoniae has not been extensively studied. However, it is known that the absorption, distribution, metabolism, and excretion of its active compounds can be influenced by the preparation method, dosage form, and individual patient factors. The bioavailability of the compounds may vary, affecting their therapeutic efficacy.

Pregnancy

Insufficient data are available to establish the safety of paeoniae during pregnancy. It is recommended to consult healthcare professionals before use.

Breast-feeding

Limited information is available on the excretion of paeoniae in human milk. Caution is advised when administering to nursing mothers.

Storage

Store in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.

Indications

• Anti-inflammatory effects
• Antioxidant support
• Immune system modulation
• Support in chronic diseases
• General wellness and health maintenance

Dosage

Children: Paediatric dosing for radix extracts should be approached with caution and is best determined by a healthcare provider, taking into account the child's age, weight, and health condition.

Adults: Dosage for radix extracts varies widely based on the specific herb and its intended use. It is advisable to refer to specific guidelines or consult with a healthcare professional for dosage recommendations.

Mechanism of action

The mechanisms of action for radix extracts are diverse and depend on the specific herb. Generally, these extracts may exert their effects through modulation of various signaling pathways, including the inhibition of pro-inflammatory cytokines, enhancement of antioxidant defenses, and regulation of immune cell activity. Many radix formulations contain bioactive compounds that interact with specific molecular targets, leading to physiological changes that contribute to their therapeutic effects.

Pharmacodynamics

Pharmacodynamics of radix extracts involves their interactions with biological systems. They may exhibit properties such as anti-inflammatory effects, reduction of oxidative stress, and modulation of cellular signaling pathways. The therapeutic effects often result from synergistic actions of multiple phytochemicals present in the extracts, which can influence various physiological processes.

Pharmacokinetics

The pharmacokinetics of radix extracts are largely dependent on the specific plant source and its constituents. Generally, these compounds are absorbed in the gastrointestinal tract, metabolized primarily by the liver, and excreted via urine or bile. The bioavailability of bioactive compounds can vary, influenced by factors such as the method of preparation, the presence of other food substances, and the individual’s metabolic rate.

Pregnancy

Lack of sufficient data on safety during pregnancy. Caution is advised.

Breast-feeding

Limited data available. Use with caution and consult a healthcare professional.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Fertility treatments
• Assisted reproductive technologies
• Semen analysis and assessment

Dosage

Children: Not applicable, as semen is not used as a medication in pediatric populations.

Adults: Semen does not have a defined dosage, as it is a biological fluid rather than a medication. In reproductive contexts, the focus is on the quality and quantity of semen rather than a dosage regimen.

Mechanism of action

Semen itself does not have a pharmacological mechanism of action like traditional drugs. However, its components, particularly spermatozoa, interact with the female reproductive system during fertilization. The seminal plasma contains various factors such as hormones, enzymes, and nutrients that support sperm function and viability.

Pharmacodynamics

The pharmacodynamics of semen are related to its role in reproduction. The seminal plasma provides a protective environment for sperm, enhances sperm motility, and facilitates the fertilization process. Additionally, the presence of prostaglandins in semen may influence uterine contractions and aid in sperm transport to the egg.

Pharmacokinetics

Semen is not absorbed in the traditional pharmacokinetic sense, as it is a biological fluid. Its components are rapidly utilized by the female reproductive system upon ejaculation. The lifespan of sperm within the female reproductive tract can vary, with viable sperm persisting for several days under optimal conditions. The distribution of seminal plasma components occurs locally within the female reproductive organs.

Pregnancy

Semen is a biological fluid and does not have a specific documented effect on pregnancy. However, exposure to infectious agents present in semen can pose risks.

Breast-feeding

There are no known specific effects of semen on breastfeeding. However, exposure to infectious agents in semen should be considered.

Storage

Semen should be stored at appropriate temperatures to maintain viability for reproductive purposes. Typically, it is stored in liquid nitrogen or at low temperatures for cryopreservation.

Mechanism of action

In the CNS, there exist strychnine-sensitive glycine binding sites as well as strychnine-insensitive glycine binding sites. The strychnine-insensitive glycine-binding site is located on the NMDA receptor complex. The strychnine-sensitive glycine receptor complex is comprised of a chloride channel and is a member of the ligand-gated ion channel superfamily. The putative antispastic activity of supplemental glycine could be mediated by glycine's binding to strychnine-sensitive binding sites in the spinal cord. This would result in increased chloride conductance and consequent enhancement of inhibitory neurotransmission. The ability of glycine to potentiate NMDA receptor-mediated neurotransmission raised the possibility of its use in the management of neuroleptic-resistant negative symptoms in schizophrenia. Animal studies indicate that supplemental glycine protects against endotoxin-induced lethality, hypoxia-reperfusion injury after liver transplantation, and D-galactosamine-mediated liver injury. Neutrophils are thought to participate in these pathologic processes via invasion of tissue and releasing such reactive oxygen species as superoxide. In vitro studies have shown that neutrophils contain a glycine-gated chloride channel that can attenuate increases in intracellular calcium and diminsh neutrophil oxidant production. This research is ealy-stage, but suggests that supplementary glycine may turn out to be useful in processes where neutrophil infiltration contributes to toxicity, such as ARDS. HYPERPOLARIZATION OF MOTONEURONS PRODUCED BY IONTOPHORETIC APPLICATION OF GLYCINE IS RELATIVELY TRANSIENT BUT APPROACHES THE EQUILIBRIUM POTENTIAL FOR THE INDIRECTLY ACTIVATED INHIBITORY POSTSYNAPTIC POTENTIAL...TESTS WITH GABA... INDICATE SIMILAR ELECTROPHYSIOLOGICAL EFFECTS & SIMILAR INCR IN CL- CONDUCTANCE. MAJOR EVIDENCE THAT FAVORS GLYCINE AS MEDIATOR OF INTRASPINAL POSTSYNAPTIC INHIBITION IS THE SELECTIVE ANTAGONISM OF ITS EFFECTS BY STRYCHNINE. ... GLYCINE ALSO APPEARS TO BE MOST LIKELY TRANSMITTER FOR INHIBITORY INTERNEURONS IN RETICULAR FORMATION BUT NOT IN CUNEATE NUCLEUS.

Pharmacodynamics

Helps trigger the release of oxygen to the energy requiring cell-making process; Important in the manufacturing of hormones responsible for a strong immune system.

Mechanism of action

Monobenzone is a depigmenting agent whose mechanism of action is not fully understood. It is proposed that it increases the excretion of melanin from the melanocytes. This effect is erratic and may take one to four months to occur while existing melanin is lost with normal sloughing of the stratum corneum. Hyperpigmented skin appears to fade more rapidly than does normal skin, and exposure to sunlight reduces the depigmenting effect of the drug. Following skin depigmentation after topical application of monobenzone, the histological studies indicate similar results as that seen in vitiligo, where the epidermis is intact but with the absence of identifiable melanocytes. ...INTERFERES WITH BIOSYNTHESIS OF MELANIN. IT INHIBITS ENZYME TYROSINASE & THEREBY PREVENTS CONVERSION OF TYROSINE TO DIHYDROXYPHENYLALANINE, PRECURSOR OF MELANIN.

Pharmacodynamics

Monobenzone is the monobenzyl ether of hydroquinone. Monobenzone, applied topically to the skin, is used as a depigmenting agent inhibitting melanin produced by polymerization of oxidation products of tyrosine and dihydroxyphenyl compounds. Monobenzone works by permanently removing color from normal skin located around skin with vitiligo.

Mechanism of action

Isoflavones are selective estrogen receptor modulators that exert estrogenic-like effects under certain experimental conditions, as they are structurally similar to mammalian 17β-estradiol. They may bind to both α and β isoforms of estrogen receptor (ER), but with binding affinities to ERβ approximately 20 times higher than that to ERα. The role of isoflavones on estrogen-dependent cancer has been studied, since they may mediate antiestrogenic actions by blocking the binding of endogenous estrogens and their receptor signalling. In cell culture, [DB01645] inhibited the proliferation of MDA-MB-231 human breast cancer cells, probably by arresting the cell cycle progression at the G2–M transition. In addition, genistein was shown to induce apoptosis, modify eicosanoid metabolism, and inhibit angiogenesis. There is an evidence that soy isoflavones may act on androgen receptors to inhibit tyrosine kinase activity, thereby blocking the growth and proliferation of cancer cells. Isoflavones may not significantly contribute to the hypolipidemic effects of soy protein, but may exert coronary benefits by improving endothelial function; in clinical trials of postmenopausal women, isoflavones improved flow-mediated dilation in women with impaired endothelial function. Some observational data suggests that isoflavones improve endothelial function by increasing the number of circulating endothelial progenitor cells, which replace damaged endothelial cells. Isoflavone may modulate the key transcription factors involved in the regulation of lipid metabolism by acting on the peroxisome proliferator-activated receptors (PPAR) alpha and gamma, which are receptors that regulate the transcription of genes involved in lipid and glucose homeostasis and lipid metabolism. Multiple biological actions of isoflavones, such as favorable effect on the blood lipid profile and inhibition of LDL cholesterol oxidation, may lead to cardio protective effects. [DB01645] has been shown to have antioxidant properties on hydrogen peroxide production _in vitro_ and blocks the formation of oxygen free radicals. Studies also suggest that at micromolar concentrations, genistein increases glucose-stimulated insulin secretion in cell lines and mouse pancreatic islets via a cAMP-dependent protein kinase mechanism. Based on the findings of experimental studies, genistein may exert a positive effect on bone formation by decreasing osteoclastic resorption factor, such as collagen C-telopeptide, and increasing osteoblastic formation markers, such as bone-alkaline phosphatase. _In vitro_, it antagonized the catabolic effects of parathyroid hormone (PTH) in osteoblasts by reversing the PTH-induced increase in soluble receptor activator of nuclear factor-xB ligand and decrease in osteoprotegerin expression.

Pharmacodynamics

Isolated soy protein with isoflavones was shown to decrease LDL cholesterol levels in randomized trials assessed by the American Heart Association. In a study of postmenopausal women, daily dietary intake of 101 mg of aglycone isoflavones (indicating [DB01645] and [DB13182]) was associated with lowered LDL cholesterol and apolipoprotein B levels by 8% and reduced systolic and diastolic blood pressure by 6.8% in hypertensive women. In a meta-analysis of randomized controlled trials of menopausal women, soy isoflavones attenuated bone loss of the spine and decreased the levels of deoxypyridinoline, a bone resorption marker, while increasing serum bone-specific alkaline phosphatase, a bone formation marker. The findings from studies investigating the effects of soy consumption on menopausal symptoms, breast cancer, and prostate cancer remain somewhat controversial and inconclusive. Consumption of soy isoflavones may decrease the markers of cancer development and progression in prostate cells, including prostate-specific antigen (PSA), testosterone, and androgen receptor in patients with prostate cancer but not in normal subjects. Although epidemiologic data in Asian women demonstrate that high soy food intake is associated with protection against breast cancer, soy foods have little effect on intermediary markers of breast cancer risk and postmenopausal soy intake may not reduce the risk of developing breast cancer. However, preliminary studies show that soy food intake reduces tumor recurrence in breast cancer patients. Soy isoflavones reported to interfere with thyroid peroxidase, which are involved in the production of thyroid hormones.